Funding

We gratefully acknowledge the continued support of EMBL member states and other funding organisations. Our funders make it possible for us to deliver open data resources, perform excellent research and provide professional training for the global scientific community.

As part of the European Molecular Biology Laboratory (EMBL), the largest part of our funding comes from the governments of EMBL’s member states

Other major funders include the UK Research and Innovation (UKRI), via the UK’s Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council, as well as the European Commission, the US National Institutes of Health, Wellcome, and members of our Industry Programme.

UK Research and Innovation has awarded major grants to support EMBL-EBI’s technical infrastructure. These funds are being used to transform EMBL-EBI’s compute infrastructure so the institute can efficiently develop and manage a diverse suite of public data services that meet the changing needs of the life global sciences community.

In 2024 our funders included:

  • Biotechnology and Biological Sciences Research Council
  • Bill & Melinda Gates Foundation
  • Cancer Research UK
  • Chan Zuckerberg Initiative
  • European Association for Cancer Research
  • European Commission
  • Engineering and Physical Sciences Research Council
  • Economic and Social Research Council
  • Fonds National de la Recherche
  • Leona M. and Harry S. Helmsley Charitable Trust
  • Leverhulme Trust
  • Mark Foundation for Cancer Research
  • Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
  • Gordon and Betty Moore Foundation
  • Medical Research Council
  • Natural Environment Research Council
  • NF1 Research Initiative
  • National Institutes of Health
  • National Institute for Health Research
  • Novo Nordisk
  • Osteosarcoma Institute
  • Research Council RCUK
  • Pezcoller Foundation
  • Wellcome Trust

We are extremely grateful to our funders for their continued support. Without them, we would not be able to deliver the world’s most comprehensive suite of open data resources for the life sciences, perform world-class computational research or support the training of the next generation of scientists. 


Related funding news

Edit